Carregant...
Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
Psoriasis is a chronic disease that requires long‐term treatment. Consequently, understanding the safety and tolerability of any potential treatment over time is critical to effective prescribing. The biologic agents currently available for the treatment of psoriasis target a number of different inf...
Guardat en:
| Publicat a: | J Eur Acad Dermatol Venereol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771721/ https://ncbi.nlm.nih.gov/pubmed/31054215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.15653 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|